CVS Health Corp vs ABRDN Physical Gold Shares ETF — how do they compare? CVS Health Corp trades at $86.25 (market cap $112.29B), while ABRDN Physical Gold Shares ETF trades at $39.92 (market cap $7.03B). The key difference: CVS Health Corp is far larger — about 16× ABRDN Physical Gold Shares ETF's market cap, and CVS Health Corp pays a 3.03% dividend while ABRDN Physical Gold Shares ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and ABRDN Physical Gold Shares ETF for 57 Days on average.
| CVS | SGOL | |
|---|---|---|
Market Cap | $112.29B | $7.03B |
Volume | 7,763,676 | 2,616,502 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $110.60 | $51.41 |
52-Week Low | $70.08 | $37.54 |
Typical Hold Time | 83 Days | 57 Days |
Enterprise Value | $174.64B | — |
Dividend Yield | 3.03% | — |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
SGOL is currently trading at $39.02, down 1.66% over the past 24 hours amid broader gold market weakness. Technical indicators show a bearish trend with moving averages and oscillators signaling selling pressure. The stock faces headwinds from rising Treasury yields and Federal Reserve rate uncertainty, though some support exists at current price levels. Recent news highlights gold's sensitivity to inflation data and monetary policy expectations.
The outlook for SGOL remains challenged by macroeconomic pressures, with gold prices facing resistance from higher interest rates and dollar strength. However, potential catalysts include geopolitical tensions and any dovish shift in Fed policy. Investors should monitor inflation trends and central bank guidance for directional cues in the gold market.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →SGOL is an ETF that is designed to track the performance of the price of gold bullion. The fund is backed by physical gold held in secured vaults, which is allocated to the ETF's custodian account. By providing direct ownership of gold without the need for physical storage or insurance, SGOL offers investors a convenient and cost-effective way to gain exposure to the gold market.
Read more on SGOL →